Recent news on Kogenate

Betaseron and Yasmin stoke sales and profits surge at Bayer  -  May 8, 2007
Pharma Times (subscription),The erectile dysfunction drug Levitra (vardenafil), was up 14.7% to 84 million euros, while sales of the haemophilia agent Kogenate (recombinant

Rosetta Genomics Ltd. Announces the Appointment of J. Michael ...  -  May 3, 2007
Earthtimes.orgEarlier in his career, he developed global strategic alliances for Farma Biagini SpA and helped successfully launch Kogenate(R) (a recombinant Factor VIII

Bayer NZ announces head of new division  -  Apr 3, 2007
Scoop.co.nz,Key brands for the new Bayer Schering Pharma business include Betaferon®, Kogenate® FS, Yasmin®, Mirena® and Levitra®. In New Zealand, Bayer Schering Pharma

Bayer and Schering Aim For Specialized Solution  -  Apr 19, 2007
St.Petersburg Times.ru,Betaferon, Yasmin, Kogenate and Adalat provide most of the sales for Bayer Schering Pharma. Bayer trademarks account for one third of the total sales,

Ipsen s Full Year 2006 Results (5º)  -  Mar 18, 2007
InfoBolsa,...mainly comprised royalties from the Kogenate(R) licence, which amounted to EUR 38.7 million for 2006, down 7.8% year-on-year (EUR 42.0 million in 2005).

Ipsen s Full Year 2006 Results (9º)  -  Mar 18, 2007
InfoBolsa,Royalties received from the Kogenate(R) licence amounted to EUR 38.7 million for 2006 against EUR 42.0 million a year earlier.

Bayer posts strong results for 2007  -  Mar 15, 2007
Pharma Times (subscription),...the erectile dysfunction drug Levitra (vardenafil), up 20.8%; the haemophilia agent Kogenate (recombinant antihaemophilic factor), climbing 18.7%;

Zacks Analyst Blog Highlights: Bayer AG and Jones Soda.  -  Mar 20, 2007
Business Wire (press release),The HealthCare division continues to improve its margins and growth in 2006 of several drugs, including Levitra, Yasmin, and Kogenate , continue be in the

Bayer has high hopes that cancer drug Nexavar will be huge  -  Mar 16, 2007
Pharma Times (subscription),However Bayer's own products faired pretty well, with the haemophilia agent Kogenate (recombinant antihaemophilic factor), climbing 18.7% to 787 million

Bayer Fourth-Quarter Net Jumps on Purchased Drugs (Update5)  -  Mar 15, 2007
BloombergSales of the Kogenate bleeding treatment jumped 16 percent to 205 million euros, while Betaseron sales rose 10 percent to 264 million euros

Bayer Fourth-Quarter Net Jumps on Purchased Drugs (Update3)  -  Mar 15, 2007
BloombergSales of the Kogenate bleeding treatment jumped 16 percent to 205 million euros. ``Health care will be the growth segment for Bayer,'' Karl- Heinz

2006 a Record Year for Bayer  -  Mar 15, 2007
PharmaLive.com (press release),The erectile dysfunction treatment Levitra® and the hemophilia drug Kogenate® posted sales growth of 20.8 and 18.7 percent, respectively.

EU-Approval For Continuous Infusion Of KOGENATE® Bayer  -  Feb 12, 2007
Medical News Today (press release),KOGENATE® Bayer, a recombinant Factor VIII product for the treatment of hemophilia A, received EU approval for continuous infusion in hemophilia A patients

EU-Approval for Continuous Infusion of KOGENATE(R) Bayer  -  Feb 9, 2007
PipelineReview.com (press release),Bayer HealthCare, manufacturer of the KOGENATE® product line, is the first to be granted the continuous infusion indication by the European Commission for

Bayer receives EU approval for continuous infusion of its Kogenate ...  -  Feb 8, 2007
Hemscott,FRANKFURT (AFX) - Bayer AG said it Bayer HealthCare unit has received EU approval for continuous infusion of its Kogenate treatment for hemophilia A

Bayer gets boost from success of Nexavar liver study  -  Feb 12, 2007
Pharma Times (subscription),Meantime, Bayer has also announced that its well-established drug Kogenate (recombinant antihaemophilic factor) has received European Union approval for

Bayer HealthCare and CSL Behring Extend Agreement for Supply of ...  -  Feb 2, 2007
PharmaLive.com (press release),1, 2007— Bayer HealthCare announced today the extension of an agreement with CSL Behring to distribute Bayer’s Recombinant Factor VIII Kogenate® under the

Bayer HealthCare and CSL Behring extend agreement for supply of ...  -  Feb 1, 2007
Prdomain Business Register (press release),This is also a collaboration that has served the global hemophilia community through expanded distribution of our reliable Kogenate® and Helixate® line of

Blood product deal gives CSL shares an infusion  -  Feb 2, 2007
The Age,Bayer supplies CSL with the recombinant blood-clotting product Kogenate, which CSL sells under the brand Helixate. CSL last year made $US340 million ($A440

Bayer Q3 profits rise, beating forecasts on strong healthcare ops ...  -  Nov 26, 2006
Forbes,...in the third quarter in the company's HealthCare division rose 72.5 pct to 3.482 bln eur, with a strong performance from its haemophilia drug Kogenate and its ...

Bayer profit falls less-than-forecast 35%  -  Nov 27, 2006
MarketWatchSales of hemophilia drug Kogenate, primary care products and cancer drugs, as well as the Yasmin contraceptive and Betaferon multiple sclerosis drug acquired ...

Bayer Q3 profits rise, beating forecasts on strong healthcare ops ...  -  Nov 27, 2006
Forbes,Third quarter sales at the division rose 72.5 pct to 3.482 bln eur, with a strong performance from its haemophilia drug Kogenate and its Oncology business. ...

Bayer Q3 profits up  -  Nov 27, 2006
Pharmaceutical Business Review...by 72.5%. Bayer HealthCare recorded good sales gains for Kogenate, key primary care products and its oncology business. The Schering ...

Bayer sees higher 2006 earnings after strong Q3  -  Nov 28, 2006
Turkish Daily News (subscription),The healthcare unit remained Bayer's star performer, with strong demand for top drugs like Kogenate for bleeding and Avelox for antibiotic boosting its sales. ...

Wenning: Schering Acquisition Provides Additional Boost to Bayer  -  Nov 27, 2006
PharmaLive.com (press release),7.4 percent. Bayer HealthCare recorded good sales gains for Kogenate®, key Primary Care products and its Oncology business. The ...

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional